# Amgen vs Gilead Sciences: stocks compared

URL: https://funkfolio.com/compare/amgn-vs-gild

> Amgen ($247.7B, P/E 26.8) and Gilead Sciences ($211.2B) compared: size, valuation, margins, debt, cash and price change.

---

## Amgen vs Gilead Sciences

Amgen (AMGN), health care, and Gilead Sciences (GILD), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Amgen is worth $247.7B on the stock market and Gilead Sciences $211.2B: Amgen is valued at 17% more. Amgen's operating margin in its latest fiscal year was 24.7% and Gilead Sciences's 34.0%. Over the past year Amgen's share price has moved +34.4% and Gilead Sciences's +31.8%.

### Key facts

- **Amgen market value:** $247.7B
- **Gilead Sciences market value:** $211.2B
- **Amgen P/E:** 26.8
- **Amgen revenue:** $36.8B FY to 2025-12-31
- **Gilead Sciences revenue:** $29.4B FY to 2025-12-31
- **Superinvestors holding both:** 5

Market values as of 18 Nov 2026, 04:50 UTC.

Amgen vs Gilead Sciences: every measure side by side

| Measure | Amgen | Gilead Sciences |
| --- | --- | --- |
| Sector | Health Care | Health Care |
| Country | United States | United States |
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size |  |  |
| Market cap | $247.7B higher | $211.2B lower |
| Revenue | $36.8B higher | $29.4B lower |
| Earnings | $7.7B lower | $8.5B higher |
| Employees | 31,500 higher | 17,000 lower |
| Total assets | $90.6B higher | $59B lower |
| Valuation |  |  |
| P/E | 26.8 | — |
| P/S | 6.7 lower | 7.2 higher |
| P/B | 17.3 higher | 16.2 lower |
| Dividend yield | 2.15% higher | 1.94% lower |
| Profitability |  |  |
| Operating margin | 24.7% lower | 34.0% higher |
| Balance sheet |  |  |
| Net assets | $8.7B lower | $22.7B higher |
| Total liabilities | $81.9B higher | $36.4B lower |
| Total debt | $54.6B higher | $24.9B lower |
| Cash on hand | $9.1B higher | $7.6B lower |
| Price change |  |  |
| Today | -0.95% lower | +1.60% higher |
| 1 year | +34.4% higher | +31.8% lower |

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

### Share price over one year

Each company's share price rebased to 100 on Nov 17, 2025, so the two lines start together. Price only: dividends are not included. Last: Amgen 134.0, Gilead Sciences 137.2.

- Amgen (AMGN)
- Gilead Sciences (GILD)

Amgen and Gilead Sciences share prices over one year, rebased to 100: Amgen ends at 134.0, Gilead Sciences at 137.2.

**The chart as a table**

Month-end share prices rebased to 100

| Month end | AMGN | GILD |
| --- | --- | --- |
| Nov 28, 2025 | 101.1 | 101.4 |
| Dec 31, 2025 | 95.8 | 98.9 |
| Jan 30, 2026 | 100.0 | 114.4 |
| Feb 27, 2026 | 113.6 | 120.0 |
| Mar 31, 2026 | 103.0 | 112.3 |
| Apr 30, 2026 | 101.3 | 105.4 |
| May 29, 2026 | 98.6 | 108.3 |
| Jun 30, 2026 | 106.0 | 101.8 |
| Jul 31, 2026 | 112.7 | 104.9 |
| Aug 31, 2026 | 125.8 | 117.9 |
| Sep 30, 2026 | 123.4 | 120.1 |
| Oct 30, 2026 | 136.4 | 137.5 |
| Nov 17, 2026 | 134.0 | 137.2 |

### Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

#### Both (5)

- [Josef Lakonishok](https://funkfolio.com/gurus/josef-lakonishok) 0.4% / 0.7%
- [David Shaw (founder)](https://funkfolio.com/gurus/david-shaw) 0.3% / 0.2%
- [Fred DiSanto](https://funkfolio.com/gurus/fred-disanto) 0.2% / 0.3%
- [Ken Griffin](https://funkfolio.com/gurus/ken-griffin) 0.1% / 0.3%
- [Dodge & Cox team](https://funkfolio.com/gurus/dodge-and-cox) &lt;0.1% / 1.7%

#### Amgen only (5)

- [Bill Smead](https://funkfolio.com/gurus/bill-smead) 5.3%
- [Howard Gleicher](https://funkfolio.com/gurus/howard-gleicher) 2.6%
- [Primecap team](https://funkfolio.com/gurus/primecap) 1.5%
- [Ken Fisher](https://funkfolio.com/gurus/ken-fisher) 0.2%
- [Mairs & Power team](https://funkfolio.com/gurus/mairs-and-power) &lt;0.1%

#### Gilead Sciences only (5)

- [Brandon Haley](https://funkfolio.com/gurus/brandon-haley) 0.9%
- [Jim Simons (1938–2024)](https://funkfolio.com/gurus/jim-simons) 0.4%
- [John Rogers](https://funkfolio.com/gurus/john-rogers) 0.3%
- [Steve Cohen](https://funkfolio.com/gurus/steve-cohen) 0.3%
- [Ray Dalio (founder)](https://funkfolio.com/gurus/bridgewater) 0.2%

Percentages are each holding's share of that investor's reported portfolio (under "Both": Amgen / Gilead Sciences). [Who owns AMGN](https://funkfolio.com/stock/AMGN/superinvestors) · [Who owns GILD](https://funkfolio.com/stock/GILD/superinvestors)

### More on Amgen

- [Amgen (AMGN) stock page](https://funkfolio.com/stock/AMGN)
- [Amgen market cap](https://funkfolio.com/stock/AMGN/market-cap)
- [Amgen revenue](https://funkfolio.com/stock/AMGN/revenue)
- [Amgen P/E ratio](https://funkfolio.com/stock/AMGN/pe-ratio)
- [Amgen operating margin](https://funkfolio.com/stock/AMGN/operating-margin)
- [Amgen total debt](https://funkfolio.com/stock/AMGN/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### More on Gilead Sciences

- [Gilead Sciences (GILD) stock page](https://funkfolio.com/stock/GILD)
- [Gilead Sciences market cap](https://funkfolio.com/stock/GILD/market-cap)
- [Gilead Sciences revenue](https://funkfolio.com/stock/GILD/revenue)
- [Gilead Sciences P/E ratio](https://funkfolio.com/stock/GILD/pe-ratio)
- [Gilead Sciences operating margin](https://funkfolio.com/stock/GILD/operating-margin)
- [Gilead Sciences total debt](https://funkfolio.com/stock/GILD/total-debt)
- [Largest health care companies](https://funkfolio.com/companies/sector/health-care)

### Further comparisons

#### Amgen against its closest peers

- [Amgen vs Thermo Fisher Scientific](https://funkfolio.com/compare/amgn-vs-tmo)
- [Amgen vs AstraZeneca](https://funkfolio.com/compare/amgn-vs-azn)
- [Amgen vs Novartis](https://funkfolio.com/compare/amgn-vs-nvs)

#### Gilead Sciences against its closest peers

- [Gilead Sciences vs Abbott Laboratories](https://funkfolio.com/compare/abt-vs-gild)
- [Gilead Sciences vs Thermo Fisher Scientific](https://funkfolio.com/compare/gild-vs-tmo)
- [Gilead Sciences vs Novo Nordisk](https://funkfolio.com/compare/gild-vs-nvo)

### Learn

- [What market capitalization is and is not](https://funkfolio.com/learn/markets/market-capitalization)
- [P/E ratio explained](https://funkfolio.com/learn/stocks/pe-ratio)
- [Market cap vs enterprise value](https://funkfolio.com/learn/markets/market-cap-vs-enterprise-value)

### Questions and answers

**Which is bigger, Amgen or Gilead Sciences?**

By market value, Amgen is the larger: $247.7B against $211.2B for Gilead Sciences. By revenue in its latest fiscal year, Amgen is the larger: $36.8B against $29.4B for Gilead Sciences.

**Which has the higher operating margin?**

Gilead Sciences: 34.0%, against 24.7% for Amgen. Operating margin is operating income as a share of revenue in the latest fiscal year.

**Which has the higher dividend yield?**

Amgen: 2.15%, against 1.94% for Gilead Sciences. Dividend yield is the last twelve months' dividends as a share of today's share price.

**Which has more debt?**

Amgen: $54.6B, against $24.9B for Gilead Sciences. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.

**Which superinvestors own both Amgen and Gilead Sciences?**

In their latest 13F filings, Josef Lakonishok, David Shaw (founder), Fred DiSanto, Ken Griffin and Dodge & Cox team hold both.

### Cite this page

Funkfolio, “Amgen vs Gilead Sciences”, data as of 18 November 2026. https://funkfolio.com/compare/amgn-vs-gild

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.
